Karayama M, Suda T, Yoh K, Usui K, et al. Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational study. Lung Cancer 2024;198:108037.
PMID: 39602849